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All over the world medicinal plants and essential oils have been used therapeutically for 
centuries, and there are many conducted scientific studies that describe their remarkable 
healing properties. It is well known, that the chemistry of essential oils is influenced by 
the local geography, weather conditions, season and time of harvest, processing, 
packaging and storing conditions. The essential oils can be used mainly to be applied to 
the skin; to be inhaled; gargled and ingested, as well as bath additives. The methods of 
their administration result in absorption through the skin or oromucosa, and by inhalation. 
 The European Union has considered the medicinal use of essential oils as herbal 
products mainly through the Traditional Herbal Medicinal Products Directive (Directive 
2004/24EC amending Directive 2001/83/EC as regards THMPs). The Herbal Medicinal 
Products Committee (HMPC) at the European Medicines Agency (EMA, London) has 
drafted and adopted guidelines which are intended to support assessment of THMPs 
considering their particular characteristics, while HMPC has established community 
monographs of herbal substances, and currently, about 13 monographs on essential oils 
(fennel, anise, peppermint, thyme, rosemary, lavender etc.), have been finalised and are 
available on EMA‟s website. In these monographs, the accepted quality, as well as the 
finally adopted indications among EU countries, together with potential risks, adverse 
reactions and contraindications in their uses, are presented, based in their longstanding 
medicinal uses and European experience. A viewpoint of the regulatory Authorities 
Experience in EU will be discussed, in detail, through Selected Examples mainly coming 
from our Balkan “Neighbourhood” (essential oils and other aromatic plants from the 
Balkan Peninsula). 
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